197 related articles for article (PubMed ID: 31471397)
1. Enhanced NLRP3 and DEFA1B Expression During the Active Stage of Parenchymal Neuro-Behçet's Disease.
Ugurel E; Erdag E; Kucukali CI; Olcay A; Sanli E; Akbayir E; Kurtuncu M; Gunduz T; Yilmaz V; Tuzun E; Vural B
In Vivo; 2019; 33(5):1493-1497. PubMed ID: 31471397
[TBL] [Abstract][Full Text] [Related]
2. Clinical features and disease course of neurological involvement in Behcet's disease: HUVAC experience.
Bolek EC; Sari A; Kilic L; Kalyoncu U; Kurne A; Oguz KK; Topcuoglu MA; Ertenli I; Karadag O
Mult Scler Relat Disord; 2020 Feb; 38():101512. PubMed ID: 31733425
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of neurological manifestations of Behçet's disease: a retrospective monocentric study in Tunisia.
Houman MH; Bellakhal S; Ben Salem T; Hamzaoui A; Braham A; Lamloum M; Monia SK; Ben Ghorbel I
Clin Neurol Neurosurg; 2013 Oct; 115(10):2015-8. PubMed ID: 23830180
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid level of neurofilament light chain is associated with increased disease activity in neuro-Behçet's disease.
Karaaslan Z; Şanlı E; Timirci-Kahraman Ö; Yılmaz V; Akbayır E; Koral G; İçöz S; Gündüz T; Küçükali Cİ; Kürtünvü M; Tüzün E
Turk J Med Sci; 2022 Aug; 52(4):1266-1273. PubMed ID: 36326394
[TBL] [Abstract][Full Text] [Related]
5. Increased complexin-1 and decreased miR-185 expression levels in Behçet's disease with and without neurological involvement.
Uğurel E; Şehitoğlu E; Tüzün E; Kürtüncü M; Çoban A; Vural B
Neurol Sci; 2016 Mar; 37(3):411-6. PubMed ID: 26577184
[TBL] [Abstract][Full Text] [Related]
6. Fractalkine (CX3CL1) levels in patients with Behçet's disease and neuro-Behçet's disease.
Ceyla I; Tuba TK; Adisen E; Banu O; Isil F; Ali GM; Turgut I; Banu B
J Neurol Sci; 2012 Apr; 315(1-2):120-2. PubMed ID: 22177089
[TBL] [Abstract][Full Text] [Related]
7. Neuro-behçet's disease in South Korea: clinical characteristics and treatment response.
Yoon DL; Kim YJ; Koo BS; Kim YG; Lee CK; Yoo B
Int J Rheum Dis; 2014 May; 17(4):453-8. PubMed ID: 24506839
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance imaging and proton magnetic resonance spectroscopy in neuro-Behçet's disease.
Park KS; Ko HJ; Yoon CH; Park SH; Cho CS; Kim HY; Choe BY; Kim WU
Clin Exp Rheumatol; 2004; 22(5):561-7. PubMed ID: 15485008
[TBL] [Abstract][Full Text] [Related]
9. Increased α-defensin-1 expression in Korean patients with Behcet's disease.
Ahn JK; Hwang JW; Oh JM; Bae EK; Lee J; Lee YS; Koh EM; Cha HS
Joint Bone Spine; 2011 Dec; 78(6):593-7. PubMed ID: 21441057
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial carrier homolog 1 (Mtch1) antibodies in neuro-Behçet's disease.
Vural B; Sehitoğlu E; Cavuş F; Yalçınkaya N; Haytural H; Küçükerden M; Ulusoy C; Uğurel E; Turan S; Bulut L; Türkoğlu R; Shugaiv E; Kürtüncü M; Atakan S; Güre AO; Gül A; Eraksoy M; Akman-Demir G; Tüzün E
J Neuroimmunol; 2013 Oct; 263(1-2):139-44. PubMed ID: 24035008
[TBL] [Abstract][Full Text] [Related]
11. Increased T-bet/GATA-3 and ROR-γt /Foxp3 Ratios in Cerebrospinal Fluid as Potential Criteria for Definite Neuro-Behçet's Disease.
Belghith M; Maghrebi O; Cherif A; Bahrini K; Saied Z; Belal S; Sassi SB; Barbouche MR; Kchaou M
J Clin Med; 2022 Jul; 11(15):. PubMed ID: 35956031
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance imaging findings and outcome of neuro-Behçet's disease: the predictive factors.
Farahangiz S; Sarhadi S; Safari A; Borhani-Haghighi A
Int J Rheum Dis; 2012 Dec; 15(6):e142-9. PubMed ID: 23253242
[TBL] [Abstract][Full Text] [Related]
13. Nutritional Status in patients with Neuro-Behçet's disease.
Erdoğan S; Sorgun MH; Kuzu Mumcu M; Kural MA; Rzayev S; Yücesan C
Turk J Med Sci; 2021 Aug; 51(4):1682-1688. PubMed ID: 33600096
[TBL] [Abstract][Full Text] [Related]
14. Parenchymal Neuro-Behçet's disease or Comorbid Behçet's disease with multiple sclerosis: A discriminative analysis of a complex clinical entity.
İsmayılov R; Talibov T; Gündüz T; Kürtüncü M
Mult Scler Relat Disord; 2024 Jul; 87():105684. PubMed ID: 38788360
[TBL] [Abstract][Full Text] [Related]
15. The Cerebrospinal Fluid Presentations of Neuro-Bechet Disease, a Way to Know the Etiopathogenesis and Improve Armamentarium.
Banerjee S; Hamzoui K; Safari A; Borhani-Haghighi A
Iran J Immunol; 2021 Sep; 18(3):170-178. PubMed ID: 34596581
[TBL] [Abstract][Full Text] [Related]
16. Lesion distribution pattern of parenchymal Neuro-Behçet's disease using probability mapping.
Emekli AS; Ersözlü E; Emekli MA; Gündüz T; Kürtüncü M
Mult Scler Relat Disord; 2022 Feb; 58():103457. PubMed ID: 34929453
[TBL] [Abstract][Full Text] [Related]
17. Laboratory and clinical correlates of brain atrophy in Neuro-Behçet's disease.
Gündüz T; Kürtüncü M; Matur Z; Tüzün E; Limon U; Tanyıldız B; İzgi B; Erdoğan N; Öge AE; Gürvit H; Bilgiç B; Akman-Demir G
J Neurol Sci; 2020 Jul; 414():116831. PubMed ID: 32380297
[TBL] [Abstract][Full Text] [Related]
18. Pseudotumoral neuro-behcet's disease: case series and review of literature.
Hadj Taieb MA; Slimane H; Mhiri M; Ben Dhia R; Daoussi N; Frih-Ayed M
Acta Neurol Belg; 2024 Apr; 124(2):431-445. PubMed ID: 38396190
[TBL] [Abstract][Full Text] [Related]
19. Primary Headache in Behçet's and Neuro-Behçet's Disease.
Beton OE; Yucesan C
Neurol India; 2022; 70(1):254-257. PubMed ID: 35263891
[TBL] [Abstract][Full Text] [Related]
20. Decreased Level of IL-37 Correlates Negatively with Inflammatory Cytokines in Cerebrospinal Fluid of Patients with Neuro-Behcet's Disease.
Ben Dhifallah I; Borhani-Haghighi A; Hamzaoui A; Hamzaoui K
Iran J Immunol; 2019 Dec; 16(4):299-310. PubMed ID: 31885007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
